Nicole Bates, who leads the advocacy strategy for polio and vaccines at the Bill & Melinda Gates Foundation, writes in the foundation’s “Impatient Optimists” blog about the launch on Thursday of a pentavalent vaccine in Indonesia. Bates, who attended the launch ceremony, writes, “Yesterday’s launch was remarkable and is testament to the progress we’re making as a global immunization and health community,” and she lists three reasons. “First, this single vaccine protects children from five diseases that are responsible for preventable illness and death among young children”; “[s]econd, the vaccine is produced by BioFarma, a company owned by the Indonesian government”; and “[l]astly, Indonesia is on track to graduate from financial support from the GAVI Alliance … at the end of 2016,” she states (8/23).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.